# Vinati Organics share price today (Vinati Organics Ltd, NSE: VINATIORGA)

> Vinati Organics share price today: ₹954.45 at the NSE close on 3 November 2026, down 42.2% in a year. Vinati Organics (NSE: VINATIORGA) is worth ₹9,897 crore, trades at a P/E of 24.1 and has closed between ₹954.45 and ₹1,664.80 over the past 52 weeks. > Vinati Organics Ltd's P/E is near the low end of its own history, higher than only 0% of past readings, and its quarterly results are still getting worse. VINATIORGA · Speciality Chemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/vinati-organics-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Slowing from a peak, from fewer quarters than usual
- Price: ₹954.45 (−42.2% in a year)
- P/E: 24.1× (lower than 100% of the last 5.5 years)
- Revenue (Sep 2026): ₹680 Cr (+23.6% on a year ago)
- Profit (Sep 2026): ₹78.0 Cr (−32.2% on a year ago)
- Operating margin: 18.0% (−12.0 points on a year ago)
- ROCE: 20%, FY26
- Profit that came in as cash: 115%, last 3 years

The main question: yearly earnings per share moved +9.5% while the share price moved −42.2%. ## What is the Vinati Organics share price today? Vinati Organics Ltd's share price was ₹954.45 at the close on 3 November 2026. It has been falling for 59 weeks. That is 28.7% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹954 and ₹1,665, and at that close it was at the low of that range. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 20 weeks running. Over the last 11 years the share price moved +365% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 25 June 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Vinati Organics this quarter? Three changes stood out: profit fell in the September 2026 quarter, lowest operating margin in 16 quarters and foreign funds (FIIs) cut their stake for 3 quarters in a row. 1. Profit fell in the September 2026 quarter Profit was ₹78 crore, -32.2% on a year earlier (₹115 crore), after 9 quarters of growth. 2. Lowest operating margin in 16 quarters Operating margin was 18% in the September 2026 quarter, against 30% a year earlier. 3. Foreign funds (FIIs) cut their stake for 3 quarters in a row From 3.8% to 3.6% of the company by the September 2026 quarter. ## What are Vinati Organics' latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Vinati Organics reported revenue of ₹680 crore, up 23.6% from ₹550 crore a year earlier, and a profit of ₹78.0 crore, down 32.2% from ₹115 crore. ### Vinati Organics results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹680 crore | ₹550 crore | +23.6% |
| Profit | ₹78.0 crore | ₹115 crore | −32.2% |
| Earnings per share | ₹7.56 | ₹11.08 | −31.8% |
| Operating margin | 18.0% | 30.0% | −12.0 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 27 May 2026, about January to March 2026; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.)

## What is the Vinati Organics share price history? Vinati Organics closed at ₹954.45 on 3 November 2026, down 42.2% from ₹1,652.30 a year earlier (31 October 2025) and down 52.9% over five years. Its highest weekly close since March 2016 was ₹2,342.45 on 9 September 2022. ### Vinati Organics share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹1,070.90 | −10.9% |
| 1 month ago · 1 Oct 2026 | ₹1,208.10 | −21.0% |
| 6 months ago · 30 Apr 2026 | ₹1,322.30 | −27.8% |
| 1 year ago · 31 Oct 2025 | ₹1,652.30 | −42.2% |
| 3 years ago · 3 Nov 2023 | ₹1,726.85 | −44.7% |
| 5 years ago · 4 Nov 2021 | ₹2,027.00 | −52.9% |
| 10 years ago · 4 Nov 2016 | ₹285.28 | +234.6% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹205.38 | +364.7% |
| Highest weekly close since March 2016 · 9 Sep 2022 | ₹2,342.45 | −59.3% |
| Lowest weekly close since March 2016 · 1 Apr 2016 | ₹190.80 | +400.2% |
| 52-week high (weekly close) · 14 Nov 2025 | ₹1,664.80 | −42.7% |
| 52-week low (weekly close) · 3 Nov 2026 | ₹954.45 | 0.0% |

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (562 weekly closes from 11 March 2016 to 3 November 2026.)

## What is the latest news on Vinati Organics? 3 Nov 2026: Vinati Organics closed at ₹954.45, down 10.9% on the week and down 21.0% on the month. Results for July to September 2026: Revenue up 23.6% and profit down 32.2% on a year earlier. ### Earlier

- 16 Sep 2026: ex-date for a dividend of ₹8.50 a share. - 27 May 2026: Vinati Organics held its results call for January to March 2026. Management guided: ATBS volume growth 15-20% FY27, minimum 15% annually for next 3 years. ## What dividend does Vinati Organics pay? Vinati Organics paid ₹8.50 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.89% at the ₹954.45 close on 3 November 2026. The last was a dividend of ₹8.50 a share, ex-date 16 September 2026. ### Vinati Organics dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 16 Sep 2026 | ₹8.50 | Dividend |
| 19 Sep 2025 | ₹7.50 | Dividend |
| 3 Sep 2024 | ₹7 | Dividend |
| 1 Sep 2023 | ₹7 | Dividend |
| 6 Sep 2022 | ₹6.50 | Dividend |
| 24 Jun 2021 | ₹6 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Vinati Organics Ltd paid out 20% of its profit as dividends in FY26, and it paid a dividend in each of its last 7 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Vinati Organics management say on the latest results call? On the call for January to March 2026, held on 27 May 2026, Vinati Organics' management guided: ATBS volume growth 15-20% FY27, minimum 15% annually for next 3 years. > “We are looking at organic expansion. We have a good pipeline of products under commissioning and in the R&D space. We feel we should be investing around 250-300 crores every year for the next 3 to 5 years. That is the growth trajectory we are targeting.”
> Management, on long-term organic growth strategy, on the call for January to March 2026

### What management guided

- Overall company volume growth approximately 15% FY27 supported across portfolio (ATBS lead, specialty chemicals double-digit, AO strong)
- Antioxidant plus Butyl phenol combined revenue goal ₹800-900 crore over next 2 years via internal consumption and premiumization. - VOPL subsidiary FY27 revenue ₹100-120 crore (vs ₹10 crore FY26), MEHQ and Guaiacol driving contribution from Q2 onwards. - Operating margin 26-27% achievable on long-term basis; normalized expectation as new product ramps and cyclical demand offset FY26 elevated approximately 32%. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/2616/Conference Call/CC-May26.pdf). (From the call for January to March 2026, 27 May 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.)

## What to watch in Vinati Organics' next results? When Vinati Organics reports October to December 2026, these are the 2 checks that show whether the story is still on course. First: VOPL revenue contribution tracking ₹100-120 crore FY27 guidance with Q2-plus realization expected - next call will show if September process completion and October production restart on track with Q2-onwards revenue ramp. - What to check (from the call)
- VOPL revenue contribution tracking ₹100-120 crore FY27 guidance with Q2-plus realization expected - next call will show if September process completion and October production restart on track with Q2-onwards revenue ramp. - ATBS volume growth realization of 15-20% FY27 goal; April to June 2026 print will indicate if October 2025 demand softness has reversed and sequential growth supports full-year 15%+ annual expectation. ## Which stock lists is Vinati Organics on? Vinati Organics is on one of our India lists: 52 week high & low. [52 week high & low 52-week position: Near 52-week low](https://www.sectoralpha.in/52-week-high-stocks-india)

## Is Vinati Organics profitable? Vinati Organics Ltd earned ₹78.0 Cr of net profit in the Sep 2026 quarter, −32.2% on the same quarter a year earlier. Full-year FY26 profit was ₹444 Cr. Over 6 years profit has grown 4.9% a year on average. That is 11.5% of the quarter's revenue. The same quarter a year earlier earned ₹115 Cr. For the full year, FY26 profit was ₹444 Cr (+9.6% on the year before). Why profit moved: revenue changed +23.6% on a year earlier and the margin moved −12.0 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −4.8% and revenue +11.7%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Vinati Organics make, and is it growing? Vinati Organics Ltd reported ₹680 Cr of revenue in the Sep 2026 quarter, +23.6% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 6 years it has grown 13.7% a year on average. The last full year, FY26, came in at ₹2,227 Cr. The last four reported quarters add to ₹2,511 Cr. FY26 revenue was ₹2,227 Cr, −0.9% on the year before. Recent pace: the last four quarters grew +11.7% on average, against 13.7% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +11.0%, against +10.0% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −5.5%, against +5.7% a year (rolling over). ## How much of every ₹100 of sales does Vinati Organics keep? Vinati Organics Ltd's operating margin was 18.0% in the Sep 2026 quarter, 12.0 percentage points lower than the same quarter a year ago. Across 7 years it has been between 25.0% and 40.0%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed −11.9 percentage points on the year while gross margin changed −13.2 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Vinati Organics' profit turning into cash? Over the last 3 years, 115% of Vinati Organics Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹558 Cr of operating cash against ₹444 Cr of profit. After ₹285 Cr of spending on assets, ₹273 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 115% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle. What to look at next: the bigger use of cash is spending on new assets, at 4.4× depreciation over three years. The next section checks what that spending is building. ## Where does Vinati Organics' cash go? Vinati Organics Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 152 days in FY26, down from 158 days in FY21. It spent ₹1,208 Cr on assets over the last 3 years. Customers take 85 days to pay, and stock sits for 110 days on average. At FY26 sales of ₹2,227 Cr, each day of that cycle ties up about ₹6.1 Cr, so roughly ₹927 Cr is tied up in the business at any time. FY26: customers took 85 days to pay and stock sat for 110 days, about 3.6 months of sales sitting as stock, for a full cycle of 152 days, shorter than FY21's 158. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 110 days. Customers pay about 85 days after that. Suppliers are paid at 43 days. Together that makes the 152-day cycle. Spending on assets: ₹1,208 Cr over the last 3 years, against ₹273 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹214 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Vinati Organics' P/E ratio, and how does it compare with its own history? Vinati Organics Ltd's P/E is 24.1×, about the lowest it has ever been. Its usual P/E (the middle reading) is 49.8×, over 5.5 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +9.5% while the price moved −42.2%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −14.0% a year; about +8.7% a year came from earnings growth and about −22.7 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. The PEG ratio and its quarterly curve, which only the second data source has, are not shown on this page: its two data sources disagree by up to 27% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Is the Vinati Organics business getting better or worse? Vinati Organics Ltd's business is slowing from a peak. Profit and EPS growth have slowed sharply (profit growth from +25.8% at its peak to −5.5% now), while ROCE is still 20.0%. This is based on 9 quarters of 4 measures, with some gaps. Why it matters: slowing from a peak is where good stories often end quietly. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution. ## How much does Vinati Organics earn on its capital? Vinati Organics Ltd earned a ROCE of 20% in FY26. That is up from a low of 19% in FY24. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 19.9% net margin and 0.62× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 19.9% net margin × 0.62× asset turnover × 1.13× leverage (assets divided by equity) ≈ 13.9% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed. The quarterly return lines and the return-on-capital-used (ROIC) line, which only the second data source has, are not shown on this page: its two data sources disagree by up to 27% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Does Vinati Organics have too much debt? Vinati Organics Ltd had ₹0.0 Cr of borrowings against ₹3,161 Cr of equity in FY26, so its debt is 0.00× its equity. Its operating profit is more than 100 times its interest bill. Over 5 years borrowings went from ₹2.0 Cr to ₹0.0 Cr. Over the last 3 of those years it spent ₹1,208 Cr on assets. The spending on assets is being paid for from cash, not new debt. The total-debt and debt-to-equity series, which only the second data source has, are not shown on this page: its two data sources disagree by up to 27% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## What is the Vinati Organics shareholding pattern? Foreign institutions cut their stake in Vinati Organics Ltd by 1.8 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 3.6% of the company. Domestic institutions moved +1.7 points over the same period, to 9.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −1.8 points over 8 quarters, to 3.6%; Domestic institutions: +1.7 points over 8 quarters, to 9.0%; Promoters: +0.0 points over 8 quarters, to 74.3%. Why the owners changed: foreign institutions moved −1.8 points and domestic institutions +1.7 points over 8 quarters, while promoters stayed about the same. One group of institutions took over shares from the other; it is not a change of mind by the people running the company. ## How far is Vinati Organics from balance-sheet trouble? For Vinati Organics Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Vinati Organics rank in its industry? 42.4 out of 100, rank 24 of 30 in Speciality Chemicals, with 82% of the evidence available. Vinati Organics Ltd scores 42.4 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 24. The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. The four parts add up to the total exactly: 10 + 17.3 + 13.2 + 1.9 = 42.4. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Vinati Organics compared with? Vinati Organics ranks 24 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 42.4 out of 100. 1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) PANAMAPET · turning · Sector-leading setup · 96% evidence 80.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.8/35 · Revenue 45.9% · Profit 100% · Operating margin change 14 points · 88% evidence Capital efficiency 15.9/25 · ROCE 19.2% · Operating margin 22% · 100% evidence Valuation 19.7/20 · P/E 5.7× · PEG 0.18 · 100% evidence Relative strength 13.9/20 · Lead over its industry 16.3% · Lead over NIFTY 500 31.3% · 1 year 68.1% · 100% evidence · 10 of 12 weeks ahead Exact sum: 30.8 + 15.9 + 19.7 + 13.9 = 80.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) YASHO · losing its lead · Most evidence points up · 78% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidence Capital efficiency 12.3/25 · ROCE 8.9% · Operating margin 21% · 100% evidence Valuation 12.7/20 · P/E 45× · PEG 1.02 · 65% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 41.1% · 1 year 103.4% · 25% evidence · 11 of 12 weeks ahead Exact sum: 30 + 12.3 + 12.7 + 12.2 = 67.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) breaking out · Evidence leans up · 68% evidence 64.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change 8 points · 83% evidence Capital efficiency 21.3/25 · ROCE 36.2% · Operating margin 48% · 95% evidence Valuation 6.6/20 · P/E 25.8× · PEG n/a · 50% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 74.5% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.8 + 21.3 + 6.6 + 12.5 = 64.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) SUNSHIEL · quiet · Evidence leans up · 81% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 12.9% · Profit 100% · Operating margin change 5 points · 88% evidence Capital efficiency 18.8/25 · ROCE 19.9% · Operating margin 16% · 100% evidence Valuation 10.8/20 · P/E 24.3× · PEG 2.21 · 100% evidence Relative strength 10.8/20 · Lead over its industry n/a · Lead over NIFTY 500 4.3% · 1 year -4% · 25% evidence · 0 of 5 weeks ahead Exact sum: 23.6 + 18.8 + 10.8 + 10.8 = 64 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) BLACKROSE · quiet · Evidence leans up · 81% evidence 60.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 8.6% · Profit 28.6% · Operating margin change 6 points · 88% evidence Capital efficiency 16.4/25 · ROCE 18.7% · Operating margin 16% · 100% evidence Valuation 10.0/20 · P/E 17.1× · PEG 4.96 · 100% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 4.4% · 1 year n/a · 25% evidence · 7 of 12 weeks ahead Exact sum: 23.6 + 16.4 + 10 + 10.9 = 60.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) TATVA · losing its lead · Evidence leans up · 93% evidence 60.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidence Capital efficiency 8.7/25 · ROCE 7.2% · Operating margin 19% · 100% evidence Valuation 11.3/20 · P/E 60.2× · PEG 1.21 · 65% evidence Relative strength 11.4/20 · Lead over its industry 7.8% · Lead over NIFTY 500 23.3% · 1 year 15.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 28.7 + 8.7 + 11.3 + 11.4 = 60.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Aether Industries Ltd](https://www.sectoralpha.in/stocks/aether-industries-ltd) AETHER · leader · Evidence leans up · 90% evidence 59.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 30.2% · Profit 28.4% · Operating margin change 1 points · 100% evidence Capital efficiency 12.8/25 · ROCE 11.9% · Operating margin 32% · 100% evidence Valuation 9.7/20 · P/E 85.1× · PEG n/a · 50% evidence Relative strength 14.8/20 · Lead over its industry 22.3% · Lead over NIFTY 500 38.6% · 1 year 114.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.4 + 12.8 + 9.7 + 14.8 = 59.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) PRIVISCL · quiet · Evidence leans up · 82% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidence Capital efficiency 18.5/25 · ROCE 22.3% · Operating margin 26% · 76% evidence Valuation 10.1/20 · P/E 33.7× · PEG n/a · 50% evidence Relative strength 7.1/20 · Lead over its industry -9.7% · Lead over NIFTY 500 4.2% · 1 year 10.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 23.7 + 18.5 + 10.1 + 7.1 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) FCL · leader · Evidence leans up · 96% evidence 59.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 91.5% · Profit 41% · Operating margin change -2 points · 88% evidence Capital efficiency 13.5/25 · ROCE 18.3% · Operating margin 16% · 100% evidence Valuation 5.7/20 · P/E 46.1× · PEG 1.92 · 100% evidence Relative strength 19.5/20 · Lead over its industry 34.1% · Lead over NIFTY 500 48.9% · 1 year 62.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.3 + 13.5 + 5.7 + 19.5 = 59 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) DMCC · quiet · Evidence leans up · 93% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.9/35 · Revenue 72.1% · Profit 34.5% · Operating margin change -6.9 points · 100% evidence Capital efficiency 8.7/25 · ROCE 14.8% · Operating margin 4.2% · 100% evidence Valuation 16.1/20 · P/E 16.9× · PEG 0.44 · 65% evidence Relative strength 7.8/20 · Lead over its industry -12.3% · Lead over NIFTY 500 0.9% · 1 year -15.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 22.9 + 8.7 + 16.1 + 7.8 = 55.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) AARTIIND · quiet · Evidence leans up · 100% evidence 55.2 out of 100 Growth Capital Valuation Relative
12. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) GALAXYSURF · leader · Evidence leans up · 81% evidence 53.9 out of 100 Growth Capital Valuation Relative
13. [Pidilite Industries Ltd](https://www.sectoralpha.in/stocks/pidilite-industries-ltd) PIDILITIND · quiet · Evidence leans up · 100% evidence 53.0 out of 100 Growth Capital Valuation Relative
14. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) DICIND · breaking out · Evidence leans up · 81% evidence 53.0 out of 100 Growth Capital Valuation Relative
15. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) KRONOX · breaking out · Evidence leans up · 74% evidence 51.8 out of 100 Growth Capital Valuation Relative
16. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) NEOGEN · leader · Evidence leans up · 90% evidence 51.5 out of 100 Growth Capital Valuation Relative
17. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) CHEMCON · breaking out · Evidence leans up · 85% evidence 51.1 out of 100 Growth Capital Valuation Relative
18. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ALKYLAMINE · quiet · Evidence leans down · 96% evidence 47.9 out of 100 Growth Capital Valuation Relative
19. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) GRAUWEIL · breaking out · Evidence leans down · 96% evidence 46.3 out of 100 Growth Capital Valuation Relative
20. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) PAUSHAKLTD · losing its lead · Evidence leans down · 85% evidence 45.8 out of 100 Growth Capital Valuation Relative
21. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) breaking out · Too little evidence to rank firmly · 53% evidence 44.0 out of 100 Growth Capital Valuation Relative
22. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ANURAS · turning · Evidence leans down · 78% evidence 43.7 out of 100 Growth Capital Valuation Relative
23. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) PLATIND · turning · Evidence leans down · 81% evidence 42.5 out of 100 Growth Capital Valuation Relative
24. Vinati Organics Ltd this page VINATIORGA · quiet · Evidence leans down · 82% evidence 42.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.0/35 · Revenue 11% · Profit -5.5% · Operating margin change -12 points · 95% evidence Capital efficiency 17.3/25 · ROCE 19.8% · Operating margin 18% · 76% evidence Valuation 13.2/20 · P/E 25× · PEG n/a · 50% evidence Relative strength 1.9/20 · Lead over its industry -35.6% · Lead over NIFTY 500 -24.3% · 1 year -40% · 100% evidence · 0 of 12 weeks ahead Exact sum: 10 + 17.3 + 13.2 + 1.9 = 42.4 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 25. [Amal Ltd](https://www.sectoralpha.in/stocks/amal-ltd) AMAL · quiet · Evidence leans down · 68% evidence 41.5 out of 100 Growth Capital Valuation Relative
26. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) AMNPLST · quiet · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative
27. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) TRANSPEK · losing its lead · Evidence leans down · 63% evidence 38.6 out of 100 Growth Capital Valuation Relative
28. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) VISHNU · losing its lead · Evidence leans down · 100% evidence 38.4 out of 100 Growth Capital Valuation Relative
29. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) CLEAN · breaking out · Evidence leans down · 85% evidence 38.1 out of 100 Growth Capital Valuation Relative
30. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) TIRUMALCHM · quiet · Most evidence points down · 68% evidence 27.2 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Speciality Chemicals](https://www.sectoralpha.in/sectors/speciality-chemicals), all 30 compared on one page. ## Which companies are close to Vinati Organics in size? Vinati Organics is the 6th largest of 30 Speciality Chemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Aarti Industries, Anupam Rasayan India and Privi Speciality Chemicals. Just below it: Alkyl Amines Chemicals, Clean Science & Technology and Galaxy Surfactants. ### Speciality Chemicals companies close in size

1. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) ₹15,806 crore
2. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ₹13,019 crore
3. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) ₹12,571 crore
4. Vinati Organics Ltd ₹10,286 crore
5. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ₹8,132 crore
6. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) ₹7,606 crore
7. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) ₹7,502 crore

[All 30 Speciality Chemicals companies, largest first](https://www.sectoralpha.in/sectors/speciality-chemicals#all-companies)

### Companies close in size in other industries

1. [JM Financial Ltd](https://www.sectoralpha.in/stocks/jm-financial-ltd) ₹10,315 crore · Finance - Investment Bankers
2. [Bluestone Jewellery & Lifestyle Ltd](https://www.sectoralpha.in/stocks/bluestone-jewellery-lifestyle-ltd) ₹10,312 crore · Diamond, Gems & Jewellery
3. Vinati Organics Ltd ₹10,286 crore
4. [Blackbuck Ltd](https://www.sectoralpha.in/stocks/blackbuck-ltd) ₹10,278 crore · Logistics
5. [Gravita India Ltd](https://www.sectoralpha.in/stocks/gravita-india-ltd) ₹10,244 crore · Recycling

## What else do people ask about Vinati Organics? ### What is Vinati Organics's share price today? Vinati Organics Ltd's share price is ₹954.45, −42.2% over the past year. The whole company is worth ₹9,897 Cr on the market. It is at its lowest price of the past 52 weeks (range ₹954 to ₹1,665), 28.7% below its 200-day average. The price has been falling for 59 weeks (as of 3 November 2026). ### What were Vinati Organics's latest quarterly results? Vinati Organics Ltd reported revenue of ₹680 Cr and net profit of ₹78.0 Cr for the Sep 2026 quarter. Revenue rose 23.6% and profit fell 32.2% compared with a year earlier. Earnings per share were ₹7.56. The operating margin was 18.0%, 12.0 percentage points lower than a year earlier (as of 3 November 2026). ### What is Vinati Organics's market cap? Vinati Organics Ltd's market capitalisation is ₹9,897 Cr at a share price of ₹954.45. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Vinati Organics performing? Vinati Organics Ltd's share price has been falling for 59 weeks. In its latest quarter, revenue rose 23.6% and profit fell 32.2% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 20 weeks running (as of 3 November 2026). ### Will Vinati Organics's share price go up? This page does not forecast Vinati Organics Ltd's share price. What it shows instead: the share price is ₹954.45, and it has been falling for 59 weeks. Its P/E of 24.1× is higher than 0% of its own last 6 years (as of 3 November 2026). ### Who owns Vinati Organics? Promoters own 74.3% of Vinati Organics Ltd, foreign institutions 3.6%, domestic institutions 9.0% and the public 13.1% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 1.8 percentage points over 8 quarters (as of 3 November 2026). ### Where is Vinati Organics in its business cycle? Vinati Organics Ltd's FY26 operating margin was 29.0%, against a 7-year range of 25.0% to 40.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 18.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Vinati Organics story? The main question: yearly earnings per share moved +9.5% while the share price moved −42.2%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Vinati Organics a stock worth studying right now? What the numbers show: Vinati Organics Ltd's P/E is near the low end of its own history, higher than only 0% of past readings, and its quarterly results are still getting worse. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Vinati Organics share price forecast for 2026? What management itself guided: ATBS volume growth 15-20% FY27, minimum 15% annually for next 3 years. ## Lists

- 52 week high & low: https://www.sectoralpha.in/52-week-high-stocks-india

This is research, not advice. We’re not SEBI-registered.